Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Summary Box: Medicare to take year to decide whether to cover prostate cancer drug Provenge
Yahoo/AP
Thursday, July 1, 2010 - 4:36pm
tags:
Dendreon, FDA, Provenge, prostate cancer
Prasco to market Zegerid generic
Bizjournals.com
Thursday, July 1, 2010 - 4:35pm
tags:
Zegerid, Prasco, generics, reflux, Santarus
Avanir shares jump on analyst outlook
Yahoo/AP
Thursday, July 1, 2010 - 4:34pm
tags:
Avanir, analysts
Grassley zeroes in on pharma whistleblowers
Fierce Pharma
Thursday, July 1, 2010 - 11:24am
tags:
Charles Grassley, whistleblowers, Pfizer, AstraZeneca, Eli Lilly
Watson starts selling generic Alzheimer's drug
Yahoo/AP
Thursday, July 1, 2010 - 11:23am
tags:
Watson Pharmaceuticals, generics, Alzheimer's disease, Exelon, Novartis
Pharma layoffs near 35K in first half of 2010
Fierce Pharma
Thursday, July 1, 2010 - 10:09am
tags:
layoffs, pharma industry
Glaxo Tries Biotech Model to Spur Drug Innovations
WSJ Online
Thursday, July 1, 2010 - 10:08am
tags:
GSK, R&D, innovation, biotech
Will The Medicare Review Unravel Provenge?
Pharmalot
Thursday, July 1, 2010 - 10:05am
tags:
Provenge, prostate cancer, Medicare, Dendreon
Hospira draws closer to finishing Javelin purchase
Yahoo/AP
Thursday, July 1, 2010 - 9:59am
tags:
Hospira, Javelin, M&A
Glaxo sells Italian R&D facility to Aptuit
Yahoo/AP
Thursday, July 1, 2010 - 9:58am
tags:
GSK, R&D, Aptuit, Italy
US FDA probes possible risks of Lilly drug, others
Reuters
Thursday, July 1, 2010 - 9:06am
tags:
FDA, Eli Lilly, Effient, Multaq, Sanofi
When is a drug too risky to stay on the market?
Yahoo/AP
Thursday, July 1, 2010 - 9:04am
tags:
GSK, Merck, Pfizer, Avandia, FDA, Tysabri
Cholesterol Drug Revives Shionogi Shares
WSJ Online
Thursday, July 1, 2010 - 8:47am
tags:
Shionogi, cholesterol, patents, Crestor, AstraZeneca
Is Bristol-Myers Squibb a Buy?
Motley Fool
Thursday, July 1, 2010 - 8:46am
tags:
Bristol-Myers Squibb
There's A Lot To Like About Teva
Forbes
Thursday, July 1, 2010 - 8:45am
tags:
Teva Pharmaceuticals, venlafaxine, antidepressants, generics, Effexor, AstraZeneca, breast cancer, Armidex
What Ails Amgen?
Investopedia
Thursday, July 1, 2010 - 8:43am
tags:
Amgen, M&A, Aranesp, anemia, oncology
Mannkind: Rodman & Renshaw Reiterates Buy on Afrezza Data
Barron's
Thursday, July 1, 2010 - 8:41am
tags:
MannKind, Afrezza, diabetes, inhaled insulin
Eisai Will Sell Arena's Hunger-Curbing Obesity Pill in the U.S. If Cleared
Bloomberg
Thursday, July 1, 2010 - 8:39am
tags:
obesity, Eisai, Arena Pharmaceuticals
Is Shire the Next Genzyme, Minus the Headaches?
Minyanville
Wednesday, June 30, 2010 - 4:05pm
tags:
Shire, Genzyme, Fabry's disease, Fabrazyme, Replagal
Report: Exelixis' Scangos named Biogen CEO
Bizjournals.com
Wednesday, June 30, 2010 - 3:35pm
tags:
Biogen Idec, Pharma CEOs, Exelixis, George Scangos

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.